NCT02471729 - Effect at 6 Months of Renal Denervation in Chronic Heart Failure d'Insuffisance Cardiaque | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 31, 2017

Primary Completion Date

September 30, 2017

Study Completion Date

January 31, 2018

Conditions

Chronic Heart Failure

Interventions

DEVICE

EnligHTN™ Renal Denervation System

The renal nerve ablation will be performed according to the EnligHTN™ Renal Denervation System Instructions for Use. This system has the CE mark and is marketed in Europe and manufactured in France. The ablation catheter is indicated for use in renal denervation procedures for the treatment of hypertension.

Trial Locations (1)

06254

Clinique Plein Ciel, Mougins